CONSORTIUM

​​​WELCOME TO ICDTD Inc., A CANADIAN KNOWLEDGE BASED CONGLOMERATE 

Intellectual Consortium of Drug Discovery and Technology Development Inc. 

EDITORIAL POLICIES 

  1. The articles are accessible online if accepted for publication.
  2. Authors and readers can study, download and/or print the open access articles.
  3. Articles are licensed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International Public License (CC BY-NC 4.0) (https://creativecommons.org/licenses/by-nc/4.0/legalcode), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided that the work is properly cited.
  4. ICDTD Inc follows the single blind peer-review procedure for submissions of all manuscripts to its journals. Single blind is the most common type of peer-reviewing in which the identity of the reviewers is not disclosed to the authors of the submitted manuscript. The anonymity of reviewers allows for objective assessment of the manuscript by reviewers and is also free from any influence by the authors on the reviewer’s comments.
  5. All submitted articles are subject to an extensive peer review in consultation with members of the Journal's Editorial Board and independent external referees; (usually three reviewers). All manuscripts are assessed rapidly and the decision taken by the journal's Editor-in-Chief based on all the peer reviewers’ comments is then conveyed to the author(s).
  6. All efforts are made to expedite the peer review process leading timely publication.
  7. Authors publishing with ICDTD Inc retain the copyright to their work.
  8. Authors have the flexibility to publish a wide range of articles in a ICDTD Inc journal e.g. short communications, full-length research and review articles, supplements, conference proceedings and case studies.
  9. For human or animal experimental investigations, it is a prerequisite to provide a formal review and approval, or review and waiver, by an appropriate institutional review board or ethics committee and should be documented in your paper.
  10. All clinical investigations must be conducted according to the Declaration of Helsinki principles. Authors must comply with the guidelines of the International Committee of Medical Journal Editors (http://www.icmje.org) with regard to the patient’s consent for research or participation in a study. Patients' names, initials, or hospital numbers must not be mentioned anywhere in the manuscript (including figures). Editors may request that authors provide documentation of the formal review and recommendation from the institutional review board or ethics committee responsible for oversight of the study.
  11. Appeals and Complaints: Authors who wish to make a complaint should refer it to the Editor-in-Chief of the journal concerned. Complaints to the Publisher may be emailed to office@icdtdi.ca
  12. Plagiarism Prevention: ICDTD Inc uses the Turnitin (http://turnitin.com/) software to detect instances of overlapping and similar text in submitted manuscripts. Turnitin software checks content against a database of periodicals, the Internet, and a comprehensive article database. It generates a similarity report, highlighting the percentage overlap between the uploaded article and the published material. Any instance of content overlap is further scrutinized for suspected plagiarism according to the publisher's Editorial Policies. ICDTD Inc allows an overall similarity of 20% for a manuscript to be considered for publication. The similarity percentage is further checked keeping the following important points in view: 
  13. Types of Plagiarism: We all know that scholarly manuscripts are written after thorough review of previously published articles. It is therefore not easy to draw a clear boundary between legitimate representation and plagiarism. However, the following important features can assist in identifying different kinds of plagiarized content. These are:
    1. Reproduction of others words, sentences, ideas or findings as one’s own without proper acknowledgement.
    2. Text recycling, also known as self-plagiarism. It is the author’s use of a previous publication in another paper without proper citation and acknowledgement of the original source.
    3. Paraphrasing poor Copying complete paragraphs and modifying a few words without changing the structure of original sentences or changing the sentence structure but not the words.
    4. Verbatim copying of text without putting quotation marks and not acknowledging the work of the original author.
    5. Properly citing a work but poorly paraphrasing the original text is considered as unintentional plagiarism. Similarly, manuscripts with language somewhere between paraphrasing and quoting are not acceptable. Authors should either paraphrase properly or quote and in both cases, cite the original source.
    6. Higher similarity in the abstract, introduction, materials and methods, and discussion and conclusion sections indicates that the manuscript may contain plagiarized text. Authors can easily explain these parts of the manuscript in many ways. However, technical terms and sometimes standard procedures cannot be rephrased; therefore, Editors must review these sections carefully before making a decision.
  14. Plagiarism in Published Manuscripts: Published manuscripts which are found to contain plagiarized text are retracted from the journal website after careful investigation and approval by the Editor-in-Chief of the journal. A ‘Retraction Note’ as well as a link to the original article is published on the electronic version of the plagiarized manuscript.
  15. Copyrights: Authors who publish in ICDTD Inc journals retain copyright to their work. Submission of a manuscript to the respective journals implies that all authors have read and agreed to the content of the Covering Letter or the Terms and Conditions. It is a condition of publication that manuscripts submitted to this journal have not been published and will not be simultaneously submitted or published elsewhere. ICDTD Inc (Licensor) grants the author(s) a worldwide, royalty-free, non-exclusive, and non-commercial perpetual license to exercise the rights in the article published as stated below:
    1. All articles are published under the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/legalcode), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided that the work is properly cited.
    2. The authors retain the copyright of their published article. They will also have the right to:
    3. Reproduce the article, to incorporate the article into one or more collective works, and to reproduce the article as incorporated in collective works;
    4. Create and reproduce Derivative Works for educational purposes.
    5. Distribute Copies
    6. Any commercial application of the work, with prior agreement by the author, is exclusively granted to ICDTD Inc.
  16. Waiver: Authors grant to ICDTD Inc (licensor) the right to retain all revenue from commercial sales of the author's published article in a ICDTD Inc journal.
  17. ICDTD Inc offers affordable article processing fees, ranking amongst the lowest as compared to those of other open access journal publishers. An article-processing fee payable by the author/ author's institution applies for every accepted article, to cover the costs incurred by open access publication. Member of ICDTD Inc are entitled to discounted article processing fees.
  18. Authors can self-archive post prints of their published articles.
  19. Authors can reproduce derivative works of the article for educational purposes and distribute its copies.
  20. Publication Charges Policy: ICDTD Inc is committed to disseminating research and scholarly publications as widely as possible. It supports the principle that 'the results of research that have been publicly funded should be freely accessible in the public domain’ and therefore it encourages researchers to make their research available through Open Access (OA).
  21. Open access publishing is not without costs. To provide open access, ICDTD Inc journals partly defray the expenses of peer review, journal production, and online hosting and archiving from authors and their research sponsors by charging a publication fee for each article they publish. The fees vary by journal.
  22. Errata and Corrections in Published Articles: Authors and readers are encouraged to notify the Editor-in-Chief if they discover errors in published content, authors’ names and affiliations or if they have reasons for concern over the legitimacy of a publication. In such cases the journal will publish an ERRATUM in consultation with Editor-in-Chief and authors of the article, and/or replace or retract the article.
  23. Article Withdrawal: Articles in Press (articles that have been accepted for publication or published as E-pub Ahead of Schedule but which have not been formally published with volume/issue/page information) that include errors, or are determined to violate the publishing ethics guidelines such as multiple submission, fake claims of authorship, plagiarism, fraudulent use of data or the like, may be “Withdrawn” from the journal. Withdrawal means that the article files are removed and replaced with a PDF stating that the article has been withdrawn from the journal in accordance with ICDTD Inc Editorial Policies.
  24. Article Retraction: Published articles (with volume/issue/page information) which may contain infringements of professional ethical codes, such as multiple submission, bogus claims of authorship, plagiarism, fraudulent use of data or the like are retracted.
    1. A retraction note titled "Retraction: [article title]" signed by the authors and/or the Editor-in-Chief is published in the paginated part of a subsequent issue of the journal and listed in the contents list.
    2. In the electronic version, a link is made to the original article.
    3. The online article is preceded by a screen containing the retraction note. It is to this screen that the link resolves; the reader can then proceed to the article itself.
    4. The original article is retained unchanged with a watermark on the .pdf indicating on each page that it is “retracted.”
    5. The HTML version of the document is removed.
  25. Redundant (multiple) publication/ Re-publication: Abstracts and posters at conferences, results presented at meetings (for example, to inform investigators or participants about findings), and results databases (data without interpretation, discussion, context or conclusions in the form of tables and text to describe data/information where this is not easily presented in tabular form) are not considered to be prior publication.
  26. Authors who want to publish translations of the articles that have been published elsewhere should ensure that they have appropriate permission(s), should indicate clearly that the material has been translated and re-published, and should indicate clearly the original source of the material. The Editor-in-Chief may request copies of related publications if they are concerned about overlap and possible redundancy.
  27. Disclaimer: Responsibility for the content published by ICDTD Inc in any of its journals, including any opinions expressed therein, rests exclusively with the author(s) of such content. To the maximum extent permitted by applicable law, ICDTD Inc (on its own behalf, and on behalf of its staff and members of its editorial board) disclaims responsibility for any and all injury and/or damage (whether financial or otherwise) to persons or property, resulting directly or indirectly from any ideas, methods, instructions or products (including errors in the same) referred to in the content of any of ICDTD Inc journals.